Search Tag: atrial fibrillation
2024 14 Oct
According to a new scientific statement from the American Heart Association, three common cardiovascular diseases in adults—heart failure, atrial fibrillation, and coronary heart disease—are closely linked to cognitive decline and an increased risk of dementia. The statement reviews current research on the relationship between cardiovascular and brain...Read more
2024 02 Sep
According to research presented at the ESC Congress 2024 in London, screening for atrial fibrillation (AF) with a wearable heart monitor over a two-week period can identify older adults with this potentially dangerous heart rhythm disorder but does not reduce the risk of subsequent strokes. However, the trial was cut short due to the COVID-19...Read more
2024 01 Sep
Adherence to atrial fibrillation (AF) guideline recommendations in clinical practice across Europe was found to be poor, but a structured educational programme for healthcare professionals significantly improved the implementation of heart rhythm control recommendations, according to research presented in a Hot Line session at the ESC Congress...Read more
2024 26 Aug
Researchers at Mass General Brigham found that women have a lower risk of developing postoperative atrial fibrillation (poAF) after surgery compared to men but face a higher risk of long-term mortality once poAF occurs. The study is published in JAMA. The objective of the research was to identify the protective factors that reduce the incidence...Read more
2024 16 Jul
A study published in Nature Medicine has demonstrated the clinical value of monitoring heart rate and physical activity using consumer wearable devices by comparing the response to two treatments for atrial fibrillation and heart failure. The study investigated whether commercially available fitness trackers and smartphones could continuously...Read more
2024 09 May
Over the past decade, late gadolinium-enhanced (LGE) cardiac MRI has been crucial in assessing left atrial (LA) fibrosis in atrial fibrillation (AF) patients, aiding in predicting AF recurrence post-ablation. This fibrotic burden can guide treatment decisions. Typically, imaging protocols involve a time-consuming diaphragm-navigated (dNAV) sequence....Read more
2024 08 May
The Food and Drug Administration (FDA) has made history by granting the Apple Watch approval as a digital health technology device. Specifically, the FDA has endorsed its atrial fibrillation (AFib) feature as a qualified tool in the Medical Device Development Tools (MDDT) programme. This feature aids in detecting irregular heart patterns and has...Read more
2024 24 Apr
Atrial fibrillation (AFib) is the most prevalent form of irregular heartbeat. It is projected to impact approximately 12.1 million adults in the United States by 2030. AFib results from abnormal electrical impulses causing a portion of the heart to quiver or fibrillate, often leading to complications and up to a fivefold increased risk of stroke....Read more
2023 25 Oct
Researchers at the Smidt Heart Institute at Cedars-Sinai have uncovered the potential of an artificial intelligence (AI) algorithm to detect abnormal heart rhythms in individuals who are not yet displaying symptoms. This innovative algorithm, capable of identifying concealed signals within common medical diagnostic tests, holds promise for aiding physicians...Read more
2022 09 Nov
The University of Cincinnati is part of a multimillion-dollar grant from the National Heart, Lung, and Blood Institute to study a strategy to prevent stroke in patients with atrial fibrillation. The trial will use an app on Apple Watch to monitor irregular heartbeat to reduce patients’ reliance on blood-thinning medication. “The individualised...Read more
2022 14 Oct
An overview of the clinical evidence demonstrating the effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter with heart failure and effective heart rate control during arrhythmias. Supraventricular arrhythmias (SVTs) are common in post-operative and cardiac ICUs. SVTs increase the risk of death...Read more
2022 29 Aug
The latest research presented at the ESC Congress in Barcelona shows that conventional smartphone-assisted atrial fibrillation (AF) screening more than doubles the detection and treatment rate in older people compared to routine screening. AF is the most common heart rhythm disorder and affects over 40 million people worldwide. People with this...Read more
2022 09 Mar
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone Almost eight times lower costs were achieved with improved detection rates and reduction of secondary stroke risk Remote cardiac monitoring via the...Read more
2021 28 Aug
In another Hot Line session at the ESC Congress 2021, findings from the ENVISAGE-TAVI AF showed that edoxaban is non-inferior to warfarin and its analogues for adverse clinical events in patients with atrial fibrillation after transcatheter aortic valve implantation. The prevalence of pre-existing or new-onset atrial fibrillation after TAVI ranges...Read more
2021 06 Jul
The RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial is the first randomised clinical trial of digoxin vs beta-blockers in patients with atrial fibrillation and heart failure symptoms. It is a unique trial as it uses patient and public involvement (PPI) in trial design and management. In other words, the RATE-AF trial...Read more
2021 22 Jun
Consumption of alcohol is associated with an increased risk of incident atrial fibrillation. Even a low spectrum of alcohol consumption could be a risk factor for atrial fibrillation. Alcohol consumption has been shown to have a consistent linear dose-response relationship when it comes to risk of AF. In a recent study, alcohol abstinence reduced...Read more
2021 09 Mar
A team of scientists from Geisinger and Tempus have found that artificial intelligence can predict risk of new atrial fibrillation (AF) and AF-related stroke. Their findings are published in Circulation. Atrial fibrillation is the most common cardiac arrhythmia and is associated with numerous health risks, including stroke and death. The study...Read more
2020 09 Jul
During the COVID-19 pandemic lockdowns, all non-critical appointments in hospitals have been postponed, and GPs and private specialists are only seeing patients with the most urgent needs. The priority for most healthcare facilities has been managing and treating COVID-19 patients. However, while this is going on, there are reports of reduced volumes...Read more
2019 26 Aug
Enhancing Atrial Fibrillation Procedure Flow Garners Profound Results One year ago, Health Management published Aiming to heal 80 percent more hearts through the power of partnership . The article outlined the bold ambitions of Oslo University Hospital – a leading center in the treatment of Atrial Fibrillation (AF) – to expand access and enhance...Read more
2019 07 Aug
A recent study published in The Lancet found that artificial intelligence (AI) technology was able to diagnose patients with intermittent atrial fibrillation even when their hearts were at a normal rhythm. The 10-second test could help identify patients at risk of unexplained heart attacks or strokes. Atrial Fibrillation currently affects 2.7...Read more
2019 12 Jun
Urgent action is needed to prevent, detect and treat atrial fibrillation to stop a substantial rise in disabling strokes. That’s the main message of a paper published in EP Europace, a journal of the European Society of Cardiology (ESC), during World Heart Rhythm Week. Atrial fibrillation is the most common heart rhythm disorder and accounts...Read more
2019 08 May
University of Minnesota Medical School researchers have determined that atrial fibrillation (Afib) is independently associated with changes that occur with aging and dementia. "Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities" published in Strokeadvances researchers’ understanding of the mechanisms underlying atrial fibrillation-related...Read more
2019 27 Mar
A South Korean study of more than 196,000 patients with atrial fibrillation (AF) showed that blood pressure control in mid-life could reduce the risk of AF-associated dementia. The findings were presented at EHRA 2019, a congress of the European Society of Cardiology (ESC). The study is the first of its kind to show that AF patients in...Read more
2019 27 Mar
The latest findings from the AVATAR-AF trial presented at EHRA 2019, a European Society of Cardiology (ESC) congress, suggest that a catheter ablation procedure that includes only the bare essentials and delivers the same outcomes can slash waiting lists for atrial fibrillation patients. Researchers claim the simplified protocol could enable 30% more...Read more
2019 07 Feb
An update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation has been released. The focused update includes revisions to the section on anticoagulation, revisions to the section on catheter ablation of atrial fibrillation (AF), revisions to the section on the management of AF complicating acute coronary syndrome...Read more
2019 24 Jan
In a small cross-sectional study, regular alcohol intake at moderate levels was found to be associated with electrical and structural changes in atrial myocardium. The study is published in Heart Rhythm. The study included 75 healthy patients with paroxysmal or persistent atrial fibrillation. Of the 75 participants, 25 were lifelong non-drinkers,...Read more
2018 22 Sep
International validation study published in Europace The European Journal of Pacing, Arrhythmias and Cardiac Electrophysiology of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). Early detection of atrial fibrillation (AF) is essential for stroke prevention. Emerging technologies such as smartphone...Read more
2018 18 Jul
Among individuals at increased risk for atrial fibrillation (AF), use of a home-based self-applied electrocardiogram (ECG) patch facilitated AF diagnosis, according to a new study published in JAMA. Further research is needed regarding clinical implications of this finding, study authors note. For approximately 20 percent of individuals who...Read more